Skip to content

Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder

Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder: Comparison of Therapist-Led and Therapist Assisted Approaches

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04922502
Enrollment
68
Registered
2021-06-10
Start date
2021-07-01
Completion date
2023-12-22
Last updated
2025-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Anxiety Disorder, Obsessive-Compulsive Disorder in Adolescence, Obsessive-Compulsive Disorder in Children, Panic Attacks, Panic Disorder, Panic With Agoraphobia, Separation Anxiety, Social Anxiety Disorder of Childhood

Keywords

obsessive-compulsive disorder, children, cognitive behavioral therapy, anxiety

Brief summary

Anxiety and obsessive-compulsive disorders are the most common mental health disorders in childhood and adolescence. A parenting intervention for youth with anxiety, called Supportive Parenting of Anxious Childhood Emotions (SPACE), has been recently developed to help target anxiety in children. In this intervention, therapists meet individually with parents to help them reduce anxiety behaviors in their children and support adaptive behaviors in their children. The purpose for the proposed study is to demonstrate the treatment efficacy of SPACE compared to a low-contact, therapist-supported bibliotherapy version of this intervention.

Detailed description

Anxiety and obsessive-compulsive disorders are the most common mental health disorders in childhood and adolescence. Parental accommodation of their children's avoidance, escape, safety behaviors are a set of parenting behaviors that have been most strongly associated with child anxiety and obsessive-compulsive disorder. Developing and testing parent-led interventions that target accommodation and parenting styles associated with anxiety has the potential to improve treatment outcomes and reach families who may not otherwise access care (for example, for youth who refuse to attend therapy). A parenting intervention for youth with anxiety has been recently developed to address these goals called Supportive Parenting of Anxious Childhood Emotions (SPACE). In this intervention, therapists meet individually with parents to help them reduce accommodation and support adaptive behaviors in their children. SPACE was recently shown to be non-inferior to individual cognitive-behavioral therapy with 88% of youth being classified as responders to SPACE. The purpose for the proposed study is to demonstrate the treatment efficacy of SPACE compared to a low-contact, therapist-supported bibliotherapy version of this intervention, providing efficacy evidence for SPACE as delivered by an independent investigatory group.

Interventions

BEHAVIORALStandard SPACE

12 one hour parent sessions over 12 weeks in which the therapist guides the parent to target anxious behaviors and support adaptive child behaviors.

4 one hour parent sessions over 12 weeks in which the therapist supports the parent in understanding and implementing content reviewed in the book Breaking Free of Child Anxiety and OCD.

Sponsors

Baylor College of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcomes assessor is blinded

Intervention model description

Randomized assignment to one of two conditions

Eligibility

Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* The child is between the ages of 7 to 17 at enrollment * The child has clinically significant symptoms of anxiety and/or OCD, as indicated by a score of 12 or higher on the Pediatric Anxiety Rating Scale (PARS). * The child is appropriate for anxiety-focused treatment (e.g., anxiety is the primary problem as diagnosed using the Anxiety Disorders Interview Schedule (ADIS), and if secondary psychopathology is present it will not interfere with treatment). * One parent/guardian is able and willing to participate in assessment and treatment (e.g., has sufficient English fluency, the decisional capacity to participate, and can commit to treatment duration). * The participating parent/guardian lives with their child at least 50% of the time. * Both parent and child are able to read and understand English. * The child is able to communicate verbally. * Participants must reside in Texas and parents must be in the state of Texas when taking calls.

Exclusion criteria

* the child has a diagnosis of child lifetime bipolar disorder, drug of alcohol abuse, intellectual or developmental disability, psychotic disorder, or conduct disorder. * the child has severe, current suicidal/homicidal ideation and/or self-injury requiring medical intervention (referrals will be made for appropriate clinical intervention). * the child is receiving concurrent evidence-based psychotherapy for anxiety, involving exposure therapy in at least 50% of sessions. * the child has initiated or changed dosage of psychotropic medications within 4 weeks before study enrollment OR stimulant or benzodiazepine medications within 2 weeks before study enrollment. If appropriate, the child may be enrolled in the study once medication dosage has stabilized (i.e., 4 weeks for psychotropic medication or 2 weeks for stimulant/benzodiazepine medication).

Design outcomes

Primary

MeasureTime frameDescription
Pediatric Anxiety Rating ScaleBaseline (before treatment), post-treatment assessment (on average 12 weeks), one month follow up; Baseline scores reported.Clinician-rated child anxiety severity throughout the past week. Each item is scored on a 0 to 5 scale (higher scores correspond to greater severity), yielding a total between 0 and 35.

Secondary

MeasureTime frameDescription
Anxiety Disorders Interview Schedule (ADIS-IV) With Clinical Severity RatingsUp to 24 weeksClinician-rated diagnostic interview that includes current anxiety disorders, depression, obsessive-compulsive disorder, and related disorders. Each diagnostic category is coded as present or absent based on symptom criteria and clinical severity ratings (CSRs), which indicate the level of clinical interference. CSRs are scored on a 0-8 scale (0 = not at all; 8 = very, very much). CSRs of 4 or above indicate the clinical levels.
Clinical Global Impression-SeverityBaseline (before treatment), post-treatment assessment (on average 12 weeks), one month follow up; Baseline scores reported.Clinician-rated child psychopathology severity rating. A single item is scored 0-6 (0= no illness; 6= extremely severe symptoms).

Countries

United States

Participant flow

Pre-assignment details

Enrollment numbers reflect both parent and child of the parent-child dyads.

Participants by arm

ArmCount
Standard SPACE
12 one hour parent sessions over 12 weeks in which the therapist guides the parent to target anxious behaviors and support adaptive child behaviors. Standard SPACE: 12 one hour parent sessions over 12 weeks in which the therapist guides the parent to target anxious behaviors and support adaptive child behaviors.
33
Bibliotherapy, Low Therapist Contact SPACE
4 one hour parent sessions over 12 weeks in which the therapist supports the parent in understanding and implementing content reviewed in the book Breaking Free of Child Anxiety and OCD. Bibliotherapy, low therapist contact SPACE: 4 one hour parent sessions over 12 weeks in which the therapist supports the parent in understanding and implementing content reviewed in the book Breaking Free of Child Anxiety and OCD.
35
Total68

Baseline characteristics

CharacteristicBibliotherapy, Low Therapist Contact SPACEStandard SPACETotal
Age, Categorical
<=18 years
35 Participants33 Participants68 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous10.2 years
STANDARD_DEVIATION 2.8
10.2 years
STANDARD_DEVIATION 2.6
10.2 years
STANDARD_DEVIATION 2.7
Clinical Global Impressions Scale-Severity3.54 units on a scale
STANDARD_DEVIATION 0.82
3.48 units on a scale
STANDARD_DEVIATION 0.67
3.51 units on a scale
STANDARD_DEVIATION 0.74
Ethnicity (NIH/OMB)
Hispanic or Latino
11 Participants10 Participants21 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
24 Participants23 Participants47 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Pediatric Anxiety Rating Scale-Revised16.51 units on a scale
STANDARD_DEVIATION 4.14
17.63 units on a scale
STANDARD_DEVIATION 2.67
17.06 units on a scale
STANDARD_DEVIATION 3.52
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
4 Participants5 Participants9 Participants
Race (NIH/OMB)
Black or African American
1 Participants1 Participants2 Participants
Race (NIH/OMB)
More than one race
6 Participants6 Participants12 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants0 Participants3 Participants
Race (NIH/OMB)
White
21 Participants21 Participants42 Participants
Region of Enrollment
United States
35 participants33 participants68 participants
Sex: Female, Male
Female
18 Participants15 Participants33 Participants
Sex: Female, Male
Male
17 Participants18 Participants35 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 330 / 35
other
Total, other adverse events
0 / 330 / 35
serious
Total, serious adverse events
0 / 330 / 35

Outcome results

Primary

Pediatric Anxiety Rating Scale

Clinician-rated child anxiety severity throughout the past week. Each item is scored on a 0 to 5 scale (higher scores correspond to greater severity), yielding a total between 0 and 35.

Time frame: Baseline (before treatment), post-treatment assessment (on average 12 weeks), one month follow up; Baseline scores reported.

Population: Three participants did not complete the standard SPACE intervention, and 4 participants did not complete the low-therapist contact SPACE intervention

ArmMeasureValue (MEAN)Dispersion
Standard SPACEPediatric Anxiety Rating Scale10.86 score on a scaleStandard Deviation 4.8
Bibliotherapy, Low Therapist Contact SPACEPediatric Anxiety Rating Scale10.96 score on a scaleStandard Deviation 6.08
Secondary

Anxiety Disorders Interview Schedule (ADIS-IV) With Clinical Severity Ratings

Clinician-rated diagnostic interview that includes current anxiety disorders, depression, obsessive-compulsive disorder, and related disorders. Each diagnostic category is coded as present or absent based on symptom criteria and clinical severity ratings (CSRs), which indicate the level of clinical interference. CSRs are scored on a 0-8 scale (0 = not at all; 8 = very, very much). CSRs of 4 or above indicate the clinical levels.

Time frame: Up to 24 weeks

Secondary

Clinical Global Impression-Severity

Clinician-rated child psychopathology severity rating. A single item is scored 0-6 (0= no illness; 6= extremely severe symptoms).

Time frame: Baseline (before treatment), post-treatment assessment (on average 12 weeks), one month follow up; Baseline scores reported.

Population: three participants did not complete the standard SPACE intervention and 4 participants did not complete the low-therapist contact SPACE intervention. Data for baseline scores reported.

ArmMeasureValue (MEAN)Dispersion
Standard SPACEClinical Global Impression-Severity2.42 score on a scaleStandard Deviation 0.89
Bibliotherapy, Low Therapist Contact SPACEClinical Global Impression-Severity2.52 score on a scaleStandard Deviation 0.93

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026